AAIPharma - PharmaKB

Company Reports

Company Reports

Disease Reports

Disease Reports

Company ReportsAAIPharma

AAIPharma

Download report

Favorite

Financial

Marketed Drugs

Clinical Trials

Financial

Stock price

No data

Company Revenue

No data

Revenue by Drug

Marketed Drugs

Therapeutic Areas:

All

Classification:

All

Include Generics:

Trade Name	Drug Name	Approved	Patent Expires	Indication
Azasan	Azathioprine	1999-06-07		Graft rejection , Crohn disease , Multiple sclerosis , Rheumatoid arthritis , Systemic lupus erythematosus , Thrombocytopenic purpura idiopathic , Ulcerative colitis
Darvocet	Acetaminophen, Propoxyphene	1982-01-01	2025-2039	Fever , Pain
Darvon-n	Propoxyphene napsylate	1982-01-01		Pain
Darvon-n w/ asa	Aspirin, Propoxyphene napsylate	1982-01-01	2023-2033	Fever, Gout, Inflammation, Osteoarthritis, Pain, Rheumatic fever, Rheumatoid arthritis
Ketoconazole	Ketoconazole	1999-07-27		Cushing syndrome, Acanthamoeba keratitis, Blastomycosis, Chronic mucocutaneous candidiasis, Coccidioidomycosis, Cutaneous candidiasis, Histoplasmosis, Leishmaniasis, Mycoses, Oral candidiasis, Paracoccidioidomycosis, Seborrheic dermatitis, Tinea pedis, Tinea versicolor, Vulvovaginal candidiasis

Clinical Trials

Therapeutic Areas:

All

Classification:

All

Approval:

All

Status:

All

Phases:

All

Drug Name

Phase 1

Phase 2

Phase 3

Phase 4

Indication

,

postoperative pain

,

postoperative pain

© 2020-2023 Collaborative Drug Discovery Inc. (CDD) | Terms of Use